Here are five things to know:
1. The study will compare the company’s InSpace product to conventional repair or partial repair for the treatment of full thickness massive rotator cuff tears.
2. InSpace is an orthopedic biodegradable balloon system.
3. The IDE study will include 184 subjects.
4. The system has been implanted in more than 5,000 patients in 15 countries.
5. Edwin J. Rogusky, MD, and Paul R. Sensiba, MD, performed the procedures at University Orthopedics Center in State College, Pa. It was the first time the balloon has been implanted in the United States.
More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
